Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Larry L Wood. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Larry L Wood har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:PRCT / PROCEPT BioRobotics Corporation | President, CEO, Director | 313 378 |
| US:EW / Edwards Lifesciences Corporation | Global President TAVR & Surg | 206 900 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Larry L Wood. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp PRCT / PROCEPT BioRobotics Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i PRCT / PROCEPT BioRobotics Corporation. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i PRCT / PROCEPT BioRobotics Corporation. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Larry L Wood som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 |
|
4 | PRCT |
PROCEPT BioRobotics Corp
Common Stock |
A - Award | 127 783 | 313 378 | 68,85 | ||||
| 2025-09-04 |
|
4 | PRCT |
PROCEPT BioRobotics Corp
Common Stock |
A - Award | 182 392 | 185 595 | 5 694,41 | ||||
| 2025-08-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 950 | 206 900 | −4,15 | 78,06 | −698 679 | 16 151 617 |
| 2025-08-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 950 | 215 850 | 4,33 | 59,26 | 530 347 | 12 790 582 |
| 2025-06-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 950 | 206 900 | −4,15 | 75,23 | −673 268 | 15 564 185 |
| 2025-06-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 950 | 215 850 | 4,33 | 59,26 | 530 347 | 12 790 582 |
| 2025-06-12 |
|
4 | PRCT |
PROCEPT BioRobotics Corp
Common Stock |
A - Award | 1 538 | 5 968 | 34,72 | ||||
| 2025-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −988 | 206 900 | −0,48 | 73,68 | −72 796 | 15 244 421 | |
| 2025-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 11 050 | 207 888 | 5,61 | ||||
| 2025-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −819 | 196 838 | −0,41 | 74,92 | −61 359 | 14 747 132 | |
| 2025-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −410 | 197 657 | −0,21 | 75,65 | −31 016 | 14 952 782 | |
| 2025-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −396 | 198 067 | −0,20 | 75,65 | −29 957 | 14 983 798 | |
| 2025-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −333 | 198 193 | −0,17 | 76,19 | −25 371 | 15 100 305 | |
| 2024-11-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −25 000 | 198 526 | −11,18 | 65,91 | −1 647 862 | 13 085 725 |
| 2024-06-06 |
|
4 | PRCT |
PROCEPT BioRobotics Corp
Common Stock |
A - Award | 1 376 | 4 430 | 45,06 | ||||
| 2024-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −985 | 223 526 | −0,44 | 86,72 | −85 419 | 19 384 152 | |
| 2024-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −695 | 224 511 | −0,31 | 85,09 | −59 138 | 19 103 619 | |
| 2024-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 8 725 | 225 206 | 4,03 | ||||
| 2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −3 541 | 216 481 | −1,61 | 85,25 | −301 870 | 18 454 983 | |
| 2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 6 675 | 220 022 | 3,13 | ||||
| 2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −395 | 213 347 | −0,18 | 85,06 | −33 599 | 18 147 274 | |
| 2024-04-19 |
|
4 | PRCT |
PROCEPT BioRobotics Corp
Common Stock |
A - Award | 3 054 | 3 054 | |||||
| 2024-02-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −317 | 213 477 | −0,15 | 86,04 | −27 275 | 18 367 536 | |
| 2023-12-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 658 | 213 794 | −3,89 | 71,86 | −622 164 | 15 363 216 |
| 2023-12-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 658 | 222 452 | 4,05 | 45,28 | 392 006 | 10 071 880 |
| 2023-11-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 402 | 213 794 | −2,46 | 65,64 | −354 565 | 14 032 543 |
| 2023-11-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 158 | 219 196 | −1,42 | 64,68 | −204 274 | 14 178 565 |
| 2023-11-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −100 | 222 354 | −0,04 | 66,21 | −6 621 | 14 722 039 |
| 2023-11-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 660 | 222 454 | 4,05 | 45,28 | 392 096 | 10 071 970 |
| 2023-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 150 | 213 794 | −2,35 | 70,26 | −361 864 | 15 022 173 |
| 2023-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 510 | 218 944 | −1,58 | 69,61 | −244 334 | 15 240 869 |
| 2023-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 660 | 222 454 | 4,05 | 45,28 | 392 096 | 10 071 970 |
| 2023-09-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 660 | 213 794 | −3,89 | 73,63 | −637 615 | 15 741 118 |
| 2023-09-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 660 | 222 454 | 4,05 | 45,28 | 392 096 | 10 071 970 |
| 2023-08-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 421 | 213 794 | −2,92 | 79,30 | −509 185 | 16 953 841 |
| 2023-08-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 421 | 220 215 | 3,00 | 45,28 | 290 722 | 9 970 596 |
| 2023-07-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 660 | 213 794 | −3,89 | 92,94 | −804 843 | 19 869 560 |
| 2023-07-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 660 | 222 454 | 4,05 | 45,28 | 392 096 | 10 071 970 |
| 2023-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 810 | 213 794 | −2,65 | 89,87 | −522 152 | 19 213 919 |
| 2023-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 850 | 219 604 | −1,28 | 90,71 | −258 528 | 19 920 626 |
| 2023-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 8 660 | 222 454 | 4,05 | 45,28 | 392 096 | 10 071 970 |
| 2023-05-24 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 421 | 213 794 | −2,92 | 84,23 | −540 841 | 18 007 845 |
| 2023-05-24 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 421 | 220 215 | 3,00 | 45,28 | 290 722 | 9 970 596 |
| 2023-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 7 775 | 213 794 | 3,77 | ||||
| 2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 472 | 206 311 | −0,71 | 88,74 | −130 625 | 18 308 013 | |
| 2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 583 | 207 783 | −1,23 | 88,74 | −229 215 | 18 438 638 | |
| 2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 5 415 | 210 366 | 2,64 | ||||
| 2023-05-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −396 | 204 951 | −0,19 | 88,10 | −34 888 | 18 056 158 | |
| 2023-05-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −383 | 205 347 | −0,19 | 87,81 | −33 631 | 18 031 495 | |
| 2023-02-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 3 235 | 205 467 | 1,60 | ||||
| 2022-12-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 936 | 202 232 | −3,32 | 76,96 | −533 772 | 15 563 092 |
| 2022-12-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −300 | 209 168 | −0,14 | 77,48 | −23 245 | 16 207 012 |
| 2022-12-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 236 | 209 468 | 3,58 | 36,75 | 265 923 | 7 697 942 |
| 2022-11-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 242 | 202 232 | −3,46 | 68,50 | −496 065 | 13 852 535 |
| 2022-11-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 209 474 | 3,58 | 36,75 | 266 144 | 7 698 162 |
| 2022-10-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 242 | 202 232 | −3,46 | 82,12 | −594 713 | 16 607 276 |
| 2022-10-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 209 474 | 3,58 | 36,75 | 266 144 | 7 698 162 |
| 2022-09-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 242 | 202 232 | −3,46 | 89,00 | −644 538 | 17 998 631 |
| 2022-09-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 209 474 | 3,58 | 36,75 | 266 144 | 7 698 162 |
| 2022-08-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 324 | 202 232 | −2,57 | 104,59 | −556 857 | 21 152 173 |
| 2022-08-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 918 | 207 556 | −0,92 | 105,03 | −201 447 | 21 799 545 |
| 2022-08-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 209 474 | 3,58 | 36,75 | 266 144 | 7 698 162 |
| 2022-07-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 242 | 202 232 | −3,46 | 95,90 | −694 486 | 19 393 423 |
| 2022-07-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 209 474 | 3,58 | 36,75 | 266 144 | 7 698 162 |
| 2022-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 479 | 202 199 | −2,17 | 100,19 | −448 738 | 20 257 715 |
| 2022-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 763 | 206 678 | −1,32 | 101,09 | −279 315 | 20 893 351 |
| 2022-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 209 441 | 3,58 | 36,75 | 266 144 | 7 696 958 |
| 2022-05-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 816 | 204 253 | −0,88 | 95,93 | −174 209 | 19 593 994 | |
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 242 | 50 688 | −12,50 | ||||
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 568 | 206 069 | −2,17 | 96,38 | −440 251 | 19 860 336 |
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 674 | 210 637 | −1,25 | 95,71 | −255 930 | 20 160 197 |
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 213 311 | 3,51 | 36,75 | 266 144 | 7 839 180 |
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −13 256 | 0 | −100,00 | ||||
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −8 007 | 206 069 | −3,74 | 100,52 | −804 864 | 20 714 059 | |
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 13 256 | 214 076 | 6,60 | ||||
| 2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −679 | 200 820 | −0,34 | 100,52 | −68 253 | 20 186 430 | |
| 2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −567 | 201 499 | −0,28 | 105,93 | −60 062 | 21 344 793 | |
| 2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 5 550 | 5 550 | |||||
| 2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 39 800 | 39 800 | |||||
| 2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 4 425 | 202 066 | 2,24 | ||||
| 2022-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 242 | 57 930 | −11,11 | ||||
| 2022-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 867 | 197 641 | −1,92 | 121,52 | −469 917 | 24 017 319 |
| 2022-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 975 | 201 508 | −1,45 | 120,25 | −357 758 | 24 232 328 |
| 2022-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −400 | 204 483 | −0,20 | 122,12 | −48 850 | 24 972 491 |
| 2022-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 204 883 | 3,66 | 36,75 | 266 144 | 7 529 451 |
| 2022-03-08 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 242 | 65 172 | −10,00 | ||||
| 2022-03-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 547 | 197 432 | −1,76 | 107,31 | −380 635 | 21 186 848 |
| 2022-03-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 000 | 200 979 | −0,99 | 106,59 | −213 185 | 21 422 879 |
| 2022-03-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 695 | 202 979 | −0,83 | 105,23 | −178 362 | 21 359 220 |
| 2022-03-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 242 | 204 674 | 3,67 | 36,75 | 266 144 | 7 521 785 |
| 2022-02-08 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −4 386 | 72 414 | −5,71 | ||||
| 2022-02-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 086 | 197 432 | −2,03 | 109,49 | −447 387 | 21 617 409 |
| 2022-02-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −300 | 201 518 | −0,15 | 110,31 | −33 094 | 22 230 101 |
| 2022-02-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 4 386 | 201 818 | 2,22 | 36,75 | 161 186 | 7 416 827 |
| 2021-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 0 | −100,00 | ||||
| 2021-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 197 432 | −3,81 | 121,49 | −951 267 | 23 986 065 |
| 2021-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 205 262 | 3,97 | 35,20 | 275 590 | 7 224 560 |
| 2021-11-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 7 830 | −50,00 | ||||
| 2021-11-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 372 134 | −2,06 | 119,79 | −937 956 | 44 577 878 |
| 2021-11-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 379 964 | 2,10 | 35,20 | 275 590 | 13 373 463 |
| 2021-10-12 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 15 660 | −33,33 | ||||
| 2021-10-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 372 134 | −2,06 | 108,00 | −845 640 | 40 190 423 |
| 2021-10-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 379 964 | 2,10 | 35,20 | 275 590 | 13 373 463 |
| 2021-09-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 23 490 | −25,00 | ||||
| 2021-09-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 372 134 | −2,06 | 122,59 | −959 880 | 45 619 852 |
| 2021-09-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 379 964 | 2,10 | 35,20 | 275 590 | 13 373 463 |
| 2021-08-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 31 320 | −20,00 | ||||
| 2021-08-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 372 134 | −2,06 | 114,14 | −893 678 | 42 473 500 |
| 2021-08-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 379 964 | 2,10 | 35,20 | 275 590 | 13 373 463 |
| 2021-07-12 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 39 150 | −16,67 | ||||
| 2021-07-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 372 134 | −2,06 | 107,48 | −841 568 | 39 996 914 |
| 2021-07-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 379 964 | 2,10 | 35,20 | 275 590 | 13 373 463 |
| 2021-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 46 980 | −14,29 | ||||
| 2021-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 372 072 | −2,06 | 99,91 | −782 295 | 37 173 666 |
| 2021-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 379 902 | 2,10 | 35,20 | 275 590 | 13 371 280 |
| 2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −16 406 | 0 | −100,00 | ||||
| 2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −8 135 | 372 072 | −2,14 | 89,49 | −728 001 | 33 296 681 | |
| 2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 772 | 380 207 | −0,46 | 89,49 | −158 576 | 34 024 682 | |
| 2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 16 406 | 381 979 | 4,49 | ||||
| 2021-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 106 | 365 573 | −0,57 | 90,40 | −190 382 | 33 047 756 | |
| 2021-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 54 810 | −12,50 | ||||
| 2021-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 367 679 | −2,09 | 92,22 | −722 083 | 33 907 313 |
| 2021-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 375 509 | 2,13 | 35,20 | 275 590 | 13 216 661 |
| 2021-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −679 | 367 679 | −0,18 | 91,75 | −62 298 | 33 734 504 | |
| 2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 5 700 | 5 700 | |||||
| 2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 44 700 | 44 700 | |||||
| 2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 4 575 | 368 358 | 1,26 | ||||
| 2021-04-12 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 62 640 | −11,11 | ||||
| 2021-04-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 363 783 | −2,11 | 85,84 | −672 108 | 31 226 219 |
| 2021-04-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 371 613 | 2,15 | 35,20 | 275 590 | 13 079 534 |
| 2021-03-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 830 | 70 470 | −10,00 | ||||
| 2021-03-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 830 | 363 483 | −2,11 | 83,99 | −657 642 | 30 528 920 |
| 2021-03-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 830 | 371 313 | 2,15 | 35,20 | 275 590 | 13 068 985 |
| 2020-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −10 722 | 0 | −100,00 | ||||
| 2020-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −9 922 | 363 483 | −2,66 | 84,16 | −835 035 | 30 590 676 |
| 2020-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −800 | 373 405 | −0,21 | 84,83 | −67 860 | 31 674 137 |
| 2020-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 722 | 374 205 | 2,95 | 21,76 | 233 311 | 8 142 696 |
| 2020-11-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −10 698 | 10 722 | −49,94 | |||
| 2020-11-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 698 | 363 483 | −2,86 | 73,27 | −783 806 | 26 631 149 |
| 2020-11-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 698 | 374 181 | 2,94 | 21,76 | 232 788 | 8 142 174 |
| 2020-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −10 698 | 21 420 | −33,31 | |||
| 2020-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 698 | 363 483 | −2,86 | 80,38 | −859 905 | 29 216 747 |
| 2020-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 698 | 374 181 | 2,94 | 21,76 | 232 788 | 8 142 174 |
| 2020-09-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −10 698 | 32 118 | −24,99 | ||||
| 2020-09-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −10 698 | 363 483 | −2,86 | 85,09 | −910 293 | 30 928 751 | |
| 2020-09-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 10 698 | 374 181 | 2,94 | 21,76 | 232 788 | 8 142 174 | |
| 2020-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −10 698 | 42 816 | −19,99 | |||
| 2020-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 698 | 363 483 | −2,86 | 78,40 | −838 717 | 28 496 833 |
| 2020-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 698 | 374 181 | 2,94 | 21,76 | 232 788 | 8 142 174 |
| 2020-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −10 698 | 53 514 | −16,66 | |||
| 2020-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −9 393 | 363 483 | −2,52 | 68,82 | −646 456 | 25 016 049 |
| 2020-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 305 | 372 876 | −0,35 | 69,47 | −90 657 | 25 903 160 |
| 2020-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 698 | 374 181 | 2,94 | 21,76 | 232 788 | 8 142 174 |
| 2020-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −10 698 | 64 212 | −14,28 | |||
| 2020-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 698 | 363 399 | −2,86 | 75,30 | −805 559 | 27 363 923 |
| 2020-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 698 | 374 097 | 2,94 | 21,76 | 232 788 | 8 140 344 |
| 2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −707 | 121 133 | −0,58 | 225,05 | −159 110 | 27 260 960 | |
| 2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −6 343 | 0 | −100,00 | ||||
| 2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −3 145 | 121 840 | −2,52 | 217,84 | −685 107 | 26 541 605 | |
| 2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −719 | 124 985 | −0,57 | 217,84 | −156 627 | 27 226 712 | |
| 2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 6 343 | 125 704 | 5,31 | ||||
| 2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 300 | 2 300 | |||||
| 2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 16 600 | 16 600 | |||||
| 2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 1 825 | 119 361 | 1,55 | ||||
| 2020-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −3 566 | 24 970 | −12,50 | |||
| 2020-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 566 | 117 536 | −2,94 | 215,00 | −766 690 | 25 270 220 |
| 2020-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 566 | 121 102 | 3,03 | 65,28 | 232 788 | 7 905 532 |
| 2020-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −3 566 | 28 536 | −11,11 | |||
| 2020-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 566 | 117 536 | −2,94 | 180,84 | −644 875 | 21 255 193 |
| 2020-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 566 | 121 102 | 3,03 | 65,28 | 232 788 | 7 905 532 |
| 2020-03-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −3 566 | 32 102 | −10,00 | |||
| 2020-03-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 566 | 117 429 | −2,95 | 207,00 | −738 162 | 24 307 722 |
| 2020-03-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 566 | 120 995 | 3,04 | 65,28 | 232 788 | 7 898 528 |
| 2020-02-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −3 566 | 35 668 | −9,09 | |||
| 2020-02-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 566 | 117 429 | −2,95 | 219,50 | −782 737 | 25 775 579 |
| 2020-02-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 566 | 120 995 | 3,04 | 65,28 | 232 788 | 7 898 528 |
| 2020-01-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −3 566 | 39 234 | −8,33 | |||
| 2020-01-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −5 002 | 0 | −100,00 | |||
| 2020-01-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 568 | 117 429 | −6,80 | 229,98 | −1 970 469 | 27 006 231 |
| 2020-01-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 566 | 125 997 | 2,91 | 65,28 | 232 788 | 8 225 059 |
| 2020-01-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 002 | 122 431 | 4,26 | 34,05 | 170 318 | 4 168 762 |
| 2019-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 724 | 0 | −100,00 | |||
| 2019-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 724 | 117 429 | −5,42 | 238,56 | −1 604 077 | 28 013 769 |
| 2019-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 724 | 124 153 | 5,73 | 41,94 | 282 005 | 5 206 960 |
| 2019-11-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 6 724 | −49,97 | |||
| 2019-11-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 117 429 | −5,41 | 239,75 | −1 610 161 | 28 153 509 |
| 2019-11-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 124 145 | 5,72 | 41,94 | 281 669 | 5 206 625 |
| 2019-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 13 440 | −33,32 | |||
| 2019-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 117 429 | −5,41 | 218,24 | −1 465 700 | 25 627 619 |
| 2019-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 124 145 | 5,72 | 41,94 | 281 669 | 5 206 625 |
| 2019-09-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 20 156 | −24,99 | |||
| 2019-09-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 117 429 | −5,41 | 219,91 | −1 476 916 | 25 823 725 |
| 2019-09-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 124 145 | 5,72 | 41,94 | 281 669 | 5 206 625 |
| 2019-08-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 26 872 | −20,00 | |||
| 2019-08-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 117 429 | −5,41 | 213,31 | −1 432 590 | 25 048 696 |
| 2019-08-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 124 145 | 5,72 | 41,94 | 281 669 | 5 206 625 |
| 2019-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 33 588 | −16,66 | |||
| 2019-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 117 429 | −5,41 | 186,95 | −1 255 533 | 21 952 867 |
| 2019-07-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 124 145 | 5,72 | 41,94 | 281 669 | 5 206 625 |
| 2019-06-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 40 304 | −14,28 | |||
| 2019-06-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 117 386 | −5,41 | 169,75 | −1 140 041 | 19 926 263 |
| 2019-06-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 124 102 | 5,72 | 41,94 | 281 669 | 5 204 835 |
| 2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 066 | 117 386 | −0,90 | 178,17 | −189 929 | 20 914 653 | |
| 2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −2 689 | 0 | −100,00 | ||||
| 2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 334 | 118 452 | −1,11 | 181,10 | −241 587 | 21 451 646 | |
| 2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −707 | 119 786 | −0,59 | 181,10 | −128 038 | 21 693 233 | |
| 2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 2 689 | 120 493 | 2,28 | ||||
| 2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 525 | 2 525 | |||||
| 2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 17 900 | 17 900 | |||||
| 2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 025 | 117 804 | 1,75 | ||||
| 2019-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 47 020 | −12,50 | |||
| 2019-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 115 779 | −5,48 | 176,34 | −1 184 299 | 20 416 458 |
| 2019-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 122 495 | 5,80 | 41,94 | 281 669 | 5 137 438 |
| 2019-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 53 736 | −11,11 | |||
| 2019-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 115 779 | −5,48 | 192,34 | −1 291 745 | 22 268 736 |
| 2019-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 122 495 | 5,80 | 41,94 | 281 669 | 5 137 438 |
| 2019-03-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 60 452 | −10,00 | |||
| 2019-03-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 115 650 | −5,49 | 170,82 | −1 147 227 | 19 755 311 |
| 2019-03-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 122 366 | 5,81 | 41,94 | 281 669 | 5 132 025 |
| 2019-02-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 67 168 | −9,09 | |||
| 2019-02-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 115 650 | −5,49 | 169,10 | −1 135 676 | 19 556 393 |
| 2019-02-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 122 366 | 5,81 | 41,94 | 281 669 | 5 132 025 |
| 2019-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 716 | 73 884 | −8,33 | |||
| 2019-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 716 | 115 650 | −5,49 | 148,15 | −994 975 | 17 133 528 |
| 2019-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 716 | 122 366 | 5,81 | 41,94 | 281 669 | 5 132 025 |
| 2018-12-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −6 300 | 0 | −100,00 | ||||
| 2018-12-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 115 650 | −5,17 | 162,66 | −1 024 758 | 18 811 608 |
| 2018-12-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 121 950 | 5,45 | 42,72 | 269 168 | 5 210 308 |
| 2018-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 6 300 | −50,00 | |||
| 2018-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 115 650 | −5,17 | 147,96 | −932 148 | 17 111 555 |
| 2018-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 121 950 | 5,45 | 42,72 | 269 168 | 5 210 308 |
| 2018-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 12 600 | −33,33 | |||
| 2018-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 115 650 | −5,17 | 142,64 | −898 632 | 16 496 297 |
| 2018-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 121 950 | 5,45 | 42,72 | 269 168 | 5 210 308 |
| 2018-09-17 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 18 900 | −25,00 | |||
| 2018-09-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 115 650 | −5,17 | 146,95 | −925 785 | 16 994 748 |
| 2018-09-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 121 950 | 5,45 | 42,72 | 269 168 | 5 210 308 |
| 2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 25 200 | −20,00 | |||
| 2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 115 650 | −5,17 | 136,73 | −861 399 | 15 812 807 |
| 2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 121 950 | 5,45 | 42,72 | 269 168 | 5 210 308 |
| 2018-07-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 31 500 | −16,67 | |||
| 2018-07-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 115 650 | −5,17 | 148,02 | −932 526 | 17 118 494 |
| 2018-07-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 121 950 | 5,45 | 42,72 | 269 168 | 5 210 308 |
| 2018-07-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −564 | 115 650 | −0,49 | 146,99 | −82 902 | 16 999 374 | |
| 2018-06-19 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 37 800 | −14,29 | |||
| 2018-06-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 116 156 | −5,14 | 151,86 | −956 718 | 17 639 445 |
| 2018-06-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 122 456 | 5,42 | 42,72 | 269 168 | 5 231 931 |
| 2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 125 | 3 125 | |||||
| 2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 21 600 | 21 600 | |||||
| 2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 500 | 116 156 | 2,20 | ||||
| 2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −9 362 | 0 | −100,00 | ||||
| 2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −4 642 | 113 656 | −3,92 | 136,43 | −633 308 | 15 506 083 | |
| 2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 9 362 | 118 298 | 8,59 | ||||
| 2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 44 100 | −12,50 | |||
| 2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 108 936 | −5,47 | 137,26 | −864 738 | 14 952 550 |
| 2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 115 236 | 5,78 | 42,72 | 269 168 | 4 923 457 |
| 2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 066 | 108 936 | −0,97 | 138,11 | −147 225 | 15 045 146 | |
| 2018-04-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 50 400 | −11,11 | |||
| 2018-04-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 110 002 | −5,42 | 138,97 | −875 511 | 15 286 973 |
| 2018-04-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 116 302 | 5,73 | 42,72 | 269 168 | 4 969 001 |
| 2018-03-19 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 56 700 | −10,00 | |||
| 2018-03-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 109 848 | −5,42 | 141,49 | −891 387 | 15 542 455 |
| 2018-03-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 116 148 | 5,74 | 42,72 | 269 168 | 4 962 442 |
| 2018-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 63 000 | −9,09 | |||
| 2018-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 109 848 | −5,42 | 134,27 | −845 901 | 14 749 349 |
| 2018-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 116 148 | 5,74 | 42,72 | 269 168 | 4 962 442 |
| 2018-01-17 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −6 300 | 69 300 | −8,33 | |||
| 2018-01-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 300 | 109 848 | −5,42 | 121,00 | −762 300 | 13 291 660 |
| 2018-01-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 6 300 | 116 148 | 5,74 | 42,72 | 269 168 | 4 962 442 |
| 2017-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −18 960 | 0 | −100,00 | |||
| 2017-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −18 960 | 109 848 | −14,72 | 114,58 | −2 172 406 | 12 586 258 |
| 2017-12-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 18 960 | 128 808 | 17,26 | 35,78 | 678 484 | 4 609 410 |
| 2017-11-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −18 960 | 18 960 | −50,00 | |||
| 2017-11-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −18 960 | 109 848 | −14,72 | 104,76 | −1 986 155 | 11 507 173 |
| 2017-11-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 18 960 | 128 808 | 17,26 | 35,78 | 678 484 | 4 609 410 |
| 2017-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −18 960 | 37 920 | −33,33 | |||
| 2017-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −18 960 | 109 848 | −14,72 | 108,54 | −2 057 901 | 11 922 850 |
| 2017-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 18 960 | 128 808 | 17,26 | 35,78 | 678 484 | 4 609 410 |
| 2017-09-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −18 960 | 56 880 | −25,00 | |||
| 2017-09-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 447 | 109 848 | −8,68 | 112,79 | −1 178 295 | 12 389 574 |
| 2017-09-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 513 | 120 295 | −6,61 | 112,32 | −956 150 | 13 511 162 |
| 2017-09-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 18 960 | 128 808 | 17,26 | 35,78 | 678 484 | 4 609 410 |
| 2017-08-30 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −18 960 | 75 840 | −20,00 | |||
| 2017-08-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −18 960 | 109 848 | −14,72 | 111,81 | −2 119 965 | 12 282 428 |
| 2017-08-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 18 960 | 128 808 | 17,26 | 35,78 | 678 484 | 4 609 410 |
| 2017-07-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −592 | 109 848 | −0,54 | 118,17 | −69 957 | 12 980 789 | |
| 2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 625 | 3 625 | |||||
| 2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 25 600 | 25 600 | |||||
| 2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 900 | 110 373 | 2,70 | ||||
| 2017-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −10 500 | 0 | −100,00 | ||||
| 2017-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −5 154 | 107 473 | −4,58 | 110,58 | −569 929 | 11 884 328 | |
| 2017-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 10 500 | 112 627 | 10,28 | ||||
| 2016-12-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 258 | 0 | −100,00 | |||
| 2016-12-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 758 | 101 944 | −9,55 | 81,71 | −879 036 | 8 329 824 |
| 2016-12-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 112 702 | −2,17 | 82,47 | −206 177 | 9 294 604 |
| 2016-12-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 258 | 115 202 | 13,01 | 44,62 | 591 506 | 5 139 726 |
| 2016-11-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 257 | 13 258 | −50,00 | |||
| 2016-11-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 457 | 101 944 | −5,08 | 92,07 | −502 436 | 9 386 155 |
| 2016-11-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 000 | 107 401 | −2,72 | 93,23 | −279 676 | 10 012 468 |
| 2016-11-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 700 | 110 401 | −2,39 | 94,20 | −254 332 | 10 399 409 |
| 2016-11-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 100 | 113 101 | −1,82 | 95,25 | −200 034 | 10 773 356 |
| 2016-11-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 257 | 115 201 | 13,00 | 44,62 | 591 461 | 5 139 682 |
| 2016-10-04 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 257 | 26 515 | −33,33 | |||
| 2016-10-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −12 841 | 101 944 | −11,19 | 119,25 | −1 531 335 | 12 157 160 |
| 2016-10-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −416 | 114 785 | −0,36 | 119,85 | −49 859 | 13 757 251 |
| 2016-10-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 257 | 115 201 | 13,00 | 44,62 | 591 461 | 5 139 682 |
| 2016-09-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 257 | 39 772 | −25,00 | |||
| 2016-09-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −11 742 | 101 944 | −10,33 | 115,20 | −1 352 624 | 11 743 452 |
| 2016-09-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 515 | 113 686 | −1,32 | 115,81 | −175 455 | 13 166 129 |
| 2016-09-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 257 | 115 201 | 13,00 | 44,62 | 591 461 | 5 139 682 |
| 2016-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 257 | 53 029 | −20,00 | |||
| 2016-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −12 857 | 101 944 | −11,20 | 114,22 | −1 468 537 | 11 644 097 |
| 2016-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −400 | 114 801 | −0,35 | 114,80 | −45 921 | 13 179 414 |
| 2016-08-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 257 | 115 201 | 13,00 | 44,62 | 591 461 | 5 139 682 |
| 2016-07-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 257 | 66 286 | −16,67 | |||
| 2016-07-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −12 657 | 101 826 | −11,06 | 98,75 | −1 249 902 | 10 055 516 |
| 2016-07-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −600 | 114 483 | −0,52 | 99,52 | −59 710 | 11 392 986 |
| 2016-07-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 257 | 115 083 | 13,02 | 44,62 | 591 461 | 5 134 435 |
| 2016-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −13 257 | 79 543 | −14,29 | |||
| 2016-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 490 | 101 826 | −6,85 | 101,62 | −761 146 | 10 347 737 |
| 2016-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 767 | 109 316 | −5,01 | 101,06 | −582 823 | 11 047 677 |
| 2016-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 13 257 | 115 083 | 13,02 | 44,62 | 591 461 | 5 134 435 |
| 2016-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −22 400 | 0 | −100,00 | ||||
| 2016-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −11 334 | 101 826 | −10,02 | 102,99 | −1 167 289 | 10 487 076 | |
| 2016-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 22 400 | 113 160 | 24,68 | ||||
| 2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 550 | 3 550 | |||||
| 2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 26 100 | 26 100 | |||||
| 2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 850 | 90 760 | 3,24 | ||||
| 2015-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 0 | −100,00 | 56,96 | −437 453 | |
| 2015-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 43 838 | −14,91 | 141,52 | −1 086 874 | 6 204 004 |
| 2015-10-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 51 518 | 17,52 | 50,96 | 391 373 | 2 625 375 |
| 2015-09-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 7 680 | −50,00 | 50,96 | −391 373 | 391 373 |
| 2015-09-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 43 838 | −14,91 | 137,50 | −1 056 000 | 6 027 774 |
| 2015-09-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 51 518 | 17,52 | 50,96 | 391 373 | 2 625 375 |
| 2015-08-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −7 680 | 15 360 | −33,33 | 50,96 | −391 373 | 782 746 | |
| 2015-08-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 43 838 | −14,91 | 152,25 | −1 169 280 | 6 674 389 |
| 2015-08-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 51 518 | 17,52 | 50,96 | 391 373 | 2 625 375 |
| 2015-07-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 23 040 | −25,00 | |||
| 2015-07-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 43 756 | −14,93 | 143,51 | −1 102 157 | 6 279 471 |
| 2015-07-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 51 436 | 17,55 | 50,96 | 391 373 | 2 621 196 |
| 2015-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 30 720 | −20,00 | |||
| 2015-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 43 756 | −14,93 | 130,47 | −1 002 010 | 5 708 889 |
| 2015-06-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 51 436 | 17,55 | 50,96 | 391 373 | 2 621 196 |
| 2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 675 | 2 675 | |||||
| 2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 21 400 | 21 400 | |||||
| 2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 150 | 43 756 | 5,17 | ||||
| 2015-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
F - Taxes | −1 791 | 0 | −100,00 | 128,32 | −229 821 | ||
| 2015-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −1 640 | 1 791 | −47,80 | ||||
| 2015-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
D - Sale to Issuer | −219 | 3 431 | −6,00 | ||||
| 2015-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 1 640 | 41 606 | 4,10 | ||||
| 2015-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 38 400 | −16,67 | |||
| 2015-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 39 966 | −16,12 | 127,12 | −976 282 | 5 080 520 |
| 2015-05-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 47 646 | 19,22 | 50,96 | 391 373 | 2 428 057 |
| 2015-04-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 46 080 | −14,29 | |||
| 2015-04-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 39 966 | −16,12 | 142,06 | −1 091 021 | 5 677 617 |
| 2015-04-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 47 646 | 19,22 | 50,96 | 391 373 | 2 428 057 |
| 2015-03-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 53 760 | −12,50 | |||
| 2015-03-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 39 757 | −16,19 | 132,62 | −1 018 522 | 5 272 576 |
| 2015-03-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 47 437 | 19,32 | 50,96 | 391 373 | 2 417 391 |
| 2015-02-09 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 61 440 | −11,11 | |||
| 2015-02-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 39 757 | −16,19 | 134,79 | −1 035 187 | 5 358 849 |
| 2015-02-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 47 437 | 19,32 | 50,96 | 391 373 | 2 417 391 |
| 2015-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 680 | 69 120 | −10,00 | |||
| 2015-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 680 | 39 757 | −16,19 | 126,60 | −972 288 | 5 033 239 |
| 2015-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 680 | 47 437 | 19,32 | 50,96 | 391 373 | 2 417 391 |
| 2014-08-19 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −90 000 | 0 | −100,00 | ||||
| 2014-08-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −33 030 | 39 757 | −45,38 | 98,02 | −3 237 581 | 3 896 960 | |
| 2014-08-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −30 722 | 72 787 | −29,68 | 97,68 | −3 000 833 | 7 109 618 | |
| 2014-08-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 90 000 | 103 509 | 666,22 | 31,47 | 2 832 300 | 3 257 429 | |
| 2014-07-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 1 135 | 13 509 | 9,17 | ||||
| 2014-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 000 | 3 000 | |||||
| 2014-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 40 300 | 40 300 | |||||
| 2014-02-24 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 2 501 | 2 501 | |||||
| 2013-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 6 400 | 6 400 | |||||
| 2013-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 47 400 | 47 400 | |||||
| 2013-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −865 | 12 002 | −6,72 | 63,66 | −55 066 | 764 047 | |
| 2012-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −76 800 | 0 | −100,00 | ||||
| 2012-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −75 136 | 12 514 | −85,72 | 83,11 | −6 244 553 | 1 040 039 | |
| 2012-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −1 664 | 87 650 | −1,86 | 83,67 | −139 227 | 7 333 676 | |
| 2012-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 76 800 | 89 314 | 613,71 | 27,77 | 2 132 736 | 2 480 250 | |
| 2012-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 650 | 3 650 | |||||
| 2012-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 37 800 | 37 800 | |||||
| 2012-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −991 | 12 514 | −7,34 | 85,49 | −84 721 | 1 069 822 | |
| 2012-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −844 | 13 505 | −5,88 | 84,99 | −71 732 | 1 147 790 |
